{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:33:52Z","timestamp":1793637232370,"version":"4.5.1"},"reference-count":119,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the kidneys lose many abilities, such as the regulation of vitamin D (VD) metabolism. Moreover, people with CKD are at a higher risk of multifactorial VD deficiency, which has been extensively associated with poor outcomes, including bone disease, cardiovascular disease, and higher mortality. Evidence is abundant in terms of the association of negative outcomes with low levels of VD, but recent studies have lowered previous high expectations regarding the beneficial effects of VD supplementation in the general population. Although controversies still exist, the diagnosis and treatment of VD have not been excluded from nephrology guidelines, and much data still supports VD supplementation in CKD patients. In this narrative review, we briefly summarize evolving controversies and useful clinical approaches, underscoring that the adverse effects of VD derivatives must be balanced against the need for effective prevention of progressive and severe secondary hyperparathyroidism. Guidelines vary, but there seems to be general agreement that VD deficiency should be avoided in CKD patients, and it is likely that one should not wait until severe SHPT is present before cautiously starting VD derivatives. Furthermore, it is emphasized that the goal should not be the complete normalization of parathyroid hormone (PTH) levels. New developments may help us to better define optimal VD and PTH at different CKD stages, but large trials are still needed to confirm that VD and precise control of these and other CKD-MBD biomarkers are unequivocally related to improved hard outcomes in this population.<\/jats:p>","DOI":"10.3390\/nu15071576","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T04:31:05Z","timestamp":1679632265000},"page":"1576","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-2273","authenticated-orcid":false,"given":"Jordi","family":"Bover","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4871-4447","authenticated-orcid":false,"given":"Elisabet","family":"Mass\u00f3","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Gifre","sequence":"additional","affiliation":[{"name":"Rheumatology Service, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3860-5219","authenticated-orcid":false,"given":"Carlo","family":"Alfieri","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Soler-Majoral","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-4851","authenticated-orcid":false,"given":"Maria","family":"Fusaro","sequence":"additional","affiliation":[{"name":"National Research Council (CNR), 56124 Pisa, Italy"},{"name":"Department of Medicine, University of Padua, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-9539","authenticated-orcid":false,"given":"Jordi","family":"Calabia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Josep Trueta, 17007 Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-6238","authenticated-orcid":false,"given":"Rosely","family":"Rodr\u00edguez-Pena","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5855-8494","authenticated-orcid":false,"given":"N\u00e9stor","family":"Rodr\u00edguez-Chitiva","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-0205","authenticated-orcid":false,"given":"V\u00edctor","family":"L\u00f3pez-B\u00e1ez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"S\u00e1nchez-Baya","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Instituto Mexicano del Seguro Social, Hospital General de Zona No. 2, Tuxtla Guti\u00e9rrez 29000, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misael C.","family":"Bustos","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Pontificia Catholic University of Chile, Santiago 8331150, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universit\u00e1rio Lisboa Norte, EPE, 1649-028 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-6667","authenticated-orcid":false,"given":"Jonathan S.","family":"Ch\u00e1vez-I\u00f1iguez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara 44280, Mexico"},{"name":"Centro Universitario de Ciencias de la Salud CUCS, Guadalajara University, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Romero-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-0184","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Valdivielso","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n Traslacional Vascular y Renal, Instituto de Investigaci\u00f3n Biom\u00e9dica IRBlleida, 25198 Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-6214","authenticated-orcid":false,"given":"Pablo","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Universitario Dr Peset, Universitat de Val\u00e8ncia Fisabio, 46017 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"G\u00f3rriz","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Cl\u00ednico, INCLIVA, Valencia University, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D.R. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Jafar","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: A new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_4","unstructured":"Brenner, B.M. (2000). The Kidney, W.B. Saunders Company. [6th ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2019.07.022","article-title":"Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"75","author":"Isakova","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-021119-034650","article-title":"Regulation and Effects of FGF23 in Chronic Kidney Disease","volume":"82","author":"Musgrove","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e10558","DOI":"10.1002\/jbm4.10558","article-title":"FGF23 and Vitamin D Metabolism","volume":"5","author":"Latic","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rayego-Mateos, S., Dolad\u00e9, N., Garc\u00eda-Carrasco, A., Diaz-Tocados, J.M., Ibarz, M., and Valdivielso, J.M. (2022). The Increase in FGF23 Induced by Calcium Is Partially Dependent on Vitamin D Signaling. Nutrients, 14.","DOI":"10.3390\/nu14132576"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfy126","article-title":"Klotho and endocrine fibroblast growth factors: Markers of chronic kidney disease progression and cardiovascular complications?","volume":"34","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000346778","article-title":"Klotho and chronic kidney disease","volume":"180","author":"Hu","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2016.09.010","article-title":"FGF23-Klotho signaling axis in the kidney","volume":"100","author":"Erben","year":"2017","journal-title":"Bone"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0192623317737469","article-title":"Pleiotropic Actions of FGF23","volume":"45","author":"Erben","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease","volume":"305","author":"Sakova","year":"2011","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis","volume":"359","author":"Mannstadt","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2017070772","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Longitudinal FGF23 Trajectories and Mortality in Patients with CKD","volume":"29","author":"Isakova","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1112766","article-title":"Suppression of Aging in Mice by the Hormone Klotho","volume":"309","author":"Kurosu","year":"2005","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0007114513001840","article-title":"A systematic review of vitamin D status in populations worldwide","volume":"111","author":"Hilger","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jean, G., Souberbielle, J.C., and Chazot, C. (2017). Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients, 9.","DOI":"10.3390\/nu9040328"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10157-012-0642-2","article-title":"High prevalence of winter 25-hydroxyvitamin D deficiency despite supplementation according to guidelines for hemodialysis patients","volume":"16","author":"Avila","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5527\/wjn.v5.i5.471","article-title":"What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?","volume":"5","author":"Molina","year":"2016","journal-title":"World J. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/kisup.2011.28","article-title":"Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: New insights into vitamin D receptor activation","volume":"1","author":"Bover","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2011.04147.x","article-title":"Vitamin D, cardiovascular disease and mortality","volume":"75","author":"Pilz","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/ndt\/gfy016","article-title":"Vitamin D status and mortality risk among patients on dialysis: A systematic review and meta-analysis of observational studies","volume":"33","author":"Zhang","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000346846","article-title":"Vitamin D treatment and mortality in chronic kidney disease: A systematic review and meta-analysis","volume":"37","author":"Duranton","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Alfieri, C., Ruzhytska, O., Vettoretti, S., Caldiroli, L., Cozzolino, M., and Messa, P. (2019). Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice. Nutrients, 11.","DOI":"10.3390\/nu11081918"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","article-title":"Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters","volume":"5","author":"Matias","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease","volume":"380","author":"Manson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of Paricalcitol on Left Ventricular Mass and Function in CKD\u2014The OPERA Trial","volume":"25","author":"Wang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.12581018","article-title":"Vitamin D and Cardiovascular Complications of CKD: What\u2019s Next?","volume":"14","author":"Banerjee","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pilz, S., Trummer, C., Theiler-Schwetz, V., Gr\u00fcbler, M.R., Verheyen, N.D., Odler, B., Karras, S.N., Zittermann, A., and M\u00e4rz, W. (2022). Critical Appraisal of Large Vitamin D Randomized Controlled Trials. Nutrients, 14.","DOI":"10.3390\/nu14020303"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Brandenburg, V., and Ketteler, M. (2022). Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future. Nutrients, 14.","DOI":"10.3390\/nu14153009"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ndt\/gfw081","article-title":"Moderator\u2019s view: Vitamin D deficiency treatment in advanced chronic kidney disease: A close look at the emperor\u2019s clothes","volume":"31","author":"Zoccali","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","author":"Levin","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nefro.2022.03.007","article-title":"Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)","volume":"42","author":"Torregrosa","year":"2022","journal-title":"Nefrologia"},{"key":"ref_41","unstructured":"Dung, T.N.T., Balezeaux, M., Granal, M., Fouque, D., Ducher, M., and Fauvel, J.-P. (2022). Prediction of all-cause mortality for chronic kidney disease patients using four models of machine learnings. Nephrol. Dial. Transplant., gfac316."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ckj\/sfz187","article-title":"Evidence in chronic kidney disease\u2013mineral and bone disorder guidelines: Is it time to treat or time to wait?","volume":"13","author":"Bover","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic Kidney Disease\u2013Mineral-Bone Disorder: A New Paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fphys.2014.00335","article-title":"The physiology of vitamin D-far more than calcium and bone","volume":"5","author":"Carlberg","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Carlberg, C. (2022). Vitamin D and Its Target Genes. Nutrients, 14.","DOI":"10.3390\/nu14071354"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhou, J.J., Robertson, G.R., and Lee, V.W. (2018). Vitamin D in Vascular Calcification: A Double-Edged Sword?. Nutrients, 10.","DOI":"10.3390\/nu10050652"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/ckj\/sfab006","article-title":"Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease","volume":"14","author":"Xu","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.14.1.18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"14","author":"Andress","year":"2008","journal-title":"Endocr. Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nefro.2020.12.019","article-title":"Hiporrespuesta o resistencia a la acci\u00f3n de la hormona paratiroidea en la enfermedad renal cr\u00f3nica","volume":"41","author":"Bover","year":"2021","journal-title":"Nefrologia"},{"key":"ref_53","first-page":"e16388","article-title":"Secondary hyperparathyroidism in chronic kidney disease: Pathophysiology and management","volume":"13","author":"Habas","year":"2021","journal-title":"Cureus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nefro.2021.12.005","article-title":"Bodas de plata: 25 a\u00f1os de la primera demostraci\u00f3n del efecto directo del f\u00f3sforo en la c\u00e9lula paratiroidea","volume":"42","author":"Bover","year":"2022","journal-title":"Nefrolog\u00eda"},{"key":"ref_55","first-page":"46","article-title":"Characteristics of bone mineral metabolism in patients with stage 3\u20135 chronic kidney disease not on dialysis: Results of the OSERCE study","volume":"33","author":"Molina","year":"2013","journal-title":"Nefrologia"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gluba-Brz\u00f3zka, A., Franczyk, B., Cia\u0142kowska-Rysz, A., Olszewski, R., and Rysz, J. (2018). Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients. Nutrients, 10.","DOI":"10.3390\/nu10060709"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ketteler, M., Bover, J., and Mazzaferro, S. (2022). Treatment of secondary hyperparathyroidism in non-dialysis CKD: An appraisal 2022s. Nephrol. Dial. Transplant., Online ahead of print.","DOI":"10.1093\/ndt\/gfac236"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"D\u2019Arrigo, G., Mallamaci, F., Pizzini, P., Leonardis, D., Tripepi, G., and Zoccali, C. (2022). CKD-MBD biomarkers and CKD progression: An analysis by the joint model. Nephrol. Dial. Transplant., Online ahead of print.","DOI":"10.1093\/ndt\/gfac212"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ndt\/gfab308","article-title":"Independent effects of parathyroid hormone and phosphate levels on hard outcomes in non-dialysis patients: Food for thought","volume":"37","author":"Torres","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in Patients with CKD: Time for Action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D","volume":"36","author":"Evenepoel","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nefro.2018.10.009","article-title":"Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications","volume":"39","author":"Bover","year":"2019","journal-title":"Nefrologia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD\u2014Diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/jcsm.12218","article-title":"European Renal Nutrition (ERN) and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Working Groups of the European Renal Association-European Dialysis Transplant Association (ERA-EDTA) Vitamin D, a modulator of musculoskeletal health in chronic kidney disease","volume":"8","author":"Molina","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/jcsm.12839","article-title":"Effects of hormonal changes on sarcopenia in chronic kidney disease: Where are we now and what can we do?","volume":"12","author":"Gungor","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e21506","DOI":"10.1097\/MD.0000000000021506","article-title":"Vitamin D supplement on prevention of fall and fracture: A Meta-analysis of Randomized Controlled Trials","volume":"99","author":"Thanapluetiwong","year":"2020","journal-title":"Medicine"},{"key":"ref_67","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 76, S1\u2013S130."},{"key":"ref_68","unstructured":"National Kidney Foundation (Am. J. Kidney Dis., 2003). K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am. J. Kidney Dis."},{"key":"ref_69","unstructured":"Institute of Medicine (IOM) of the National Academies (2023, February 27). Dietary Reference Intakes for Calcium and Vitamin D. Available online: https:\/\/nap.nationalacademies.org\/resource\/13050\/Vitamin-D-and-Calcium-2010-Report-Brief.pdf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know","volume":"96","author":"Ross","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"96","author":"Holick","year":"2011","journal-title":"Med. J. Clin. Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2011-2218","article-title":"IOM Committee Members Respond to Endocrine Society Vitamin D Guideline","volume":"97","author":"Rosen","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cca.2019.11.010","article-title":"Nutritional vitamin D in CKD: Should we measure? Should we treat?","volume":"501","author":"Capelli","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jsbmb.2012.09.032","article-title":"Health is better at serum 25(OH)D above 30 ng\/mL","volume":"136","author":"Heaney","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000499187","article-title":"Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease","volume":"49","author":"Strugnell","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.090728","article-title":"Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients","volume":"25","author":"Priemel","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1026663","DOI":"10.3389\/fragi.2022.1026663","article-title":"25-OH vitamin D threshold for optimal bone mineral density in elderly patients with chronic kidney disease","volume":"3","author":"Roy","year":"2022","journal-title":"Front. Aging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-015-3219-6","article-title":"Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults","volume":"27","author":"Olmos","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4321\/S1889-836X2016000200002","article-title":"Hiperparatiroidismo secundario al d\u00e9ficit de vitamina D","volume":"8","author":"Rubert","year":"2016","journal-title":"Rev. de Osteoporos. y Metab. Miner."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cesareo, R., Attanasio, R., Caputo, M., Castello, R., Chiodini, I., Falchetti, A., Guglielmi, R., Papini, E., Santonati, A., and Scillitani, A. (2018). AME and Italian AACE Chapter.Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients, 10.","DOI":"10.3390\/nu10050546"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.medcli.2021.05.007","article-title":"Osteoporosis in chronic kidney disease: A essential challenge","volume":"158","author":"Casado","year":"2021","journal-title":"Med. Clin."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.ajkd.2021.06.031","article-title":"Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review","volume":"79","author":"Ginsberg","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Bargagli, M., Arena, M., Naticchia, A., Gambaro, G., Mazzaferro, S., Fuster, D., and Ferraro, P. (2021). The Role of Diet in Bone and Mineral Metabolism and Secondary Hyperparathyroidism. Nutrients, 13.","DOI":"10.3390\/nu13072328"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000338299","article-title":"Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease","volume":"35","author":"Viaene","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/978-1-4614-0887-1_5","article-title":"FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?","volume":"728","author":"Razzaque","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2054358120944271","DOI":"10.1177\/2054358120944271","article-title":"Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder","volume":"7","author":"Holden","year":"2020","journal-title":"Can. J. Kidney Health Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ekir.2019.09.007","article-title":"2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report","volume":"4","author":"Wang","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Burton, J., Goldsmith, D.J., Ruddock, N., Shroff, R., and Wan, M. (2018). Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1037-8"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ckj\/sfab035","article-title":"Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: A meta-analysis","volume":"14","author":"Bover","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfx059","article-title":"High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: Results of a 12-week double-blind, randomized, controlled study","volume":"33","author":"Westerberg","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/gfaa195","article-title":"The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation","volume":"36","author":"Tabibzadeh","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Reichel, H., Seibert, E., Tillmann, F.-P., Barck, I., Grava, A., Schneider, K.M., and Meise, D. (2022). Economic burden of secondary hyperparathyroidism in Germany: A matched comparison. Int. Urol. Nephrol.","DOI":"10.1007\/s11255-022-03425-9"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Barbuto, S., Perrone, V., Veronesi, C., Dovizio, M., Zappulo, F., Vetrano, D., Giannini, S., Fusaro, M., Ancona, D.D., and Barbieri, A. (2023). Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population. Nutrients, 15.","DOI":"10.3390\/nu15020336"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfab184","article-title":"Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: An analysis from the NEFRONA cohort","volume":"37","author":"Bozic","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-139X.2009.00581.x","article-title":"Parathyroid hormone, a uremic toxin","volume":"22","author":"Rodriguez","year":"2009","journal-title":"Semin. Dial."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40620-020-00916-9","article-title":"Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: The PECERA study","volume":"34","author":"Molina","year":"2021","journal-title":"J. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/ndt\/gfac167","article-title":"Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia","volume":"37","author":"Mathur","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ki.2014.316","article-title":"Molecular interactions of FGF23 and PTH in phosphate regulation","volume":"86","author":"Lanske","year":"2014","journal-title":"Kidney Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5414\/CN110747","article-title":"Effect of vitamin D sterols on bone histology in pre-dialysis patients: A prospective controlled study","volume":"98","author":"Neto","year":"2022","journal-title":"Clin. Nephrol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","article-title":"Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment","volume":"100","author":"Haarhaus","year":"2021","journal-title":"Kidney Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/15701611113119990024","article-title":"Vitamin D metabolites and\/or analogs: Which D for which patient?","volume":"12","author":"Mazzaferro","year":"2014","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nefro.2018.07.004","article-title":"Native vitamin D in pre-dialysis chronic kidney disease","volume":"39","author":"Cardoso","year":"2019","journal-title":"Nefrologia"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000450766","article-title":"Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease","volume":"44","author":"Sprague","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Germain, M.J., Paul, S.K., Fadda, G., Broumand, V., Nguyen, A., McGarvey, N.H., Gitlin, M.D., Bishop, C.W., Csomor, P., and Strugnell, S. (2022). Real-world assessment: Effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients. BMC Nephrol., 23.","DOI":"10.1186\/s12882-022-02993-3"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Alshabrawy, A.K., Cui, Y., Sylvester, C., Yang, D., Petito, E.S., Barratt, K.R., Sawyer, R.K., Heatlie, J.K., Polara, R., and Sykes, M.J. (2022). Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules, 12.","DOI":"10.3390\/biom12070960"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Haarhaus, M., Cianciolo, G., Barbuto, S., La Manna, G., Gasperoni, L., Tripepi, G., Plebani, M., Fusaro, M., and Magnusson, P. (2022). Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease. Nutrients, 14.","DOI":"10.3390\/nu14102124"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/0886022X.2022.2107543","article-title":"Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort","volume":"44","author":"Rios","year":"2022","journal-title":"Ren. Fail."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Lee, S., Chung, H.J., Jung, S., Jang, H.N., Chang, S.-H., Kim, H.-J., and Cho, M.-C. (2023). 24,25-Dihydroxy Vitamin D and Vitamin D Metabolite Ratio as Biomarkers of Vitamin D in Chronic Kidney Disease. Nutrients, 15.","DOI":"10.3390\/nu15030578"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Khan, S.S., Petkovich, M., Holden, R.M., and Adams, M.A. (2022). Megalin and Vitamin D Metabolism\u2014Implications in Non-Renal Tissues and Kidney Disease. Nutrients, 14.","DOI":"10.3390\/nu14183690"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1038\/s41598-022-15033-9","article-title":"The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease","volume":"12","author":"Turner","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Gembillo, G., Siligato, R., Amatruda, M., Conti, G., and Santoro, D. (2021). Vitamin D and Glomerulonephritis. Medicina, 57.","DOI":"10.3390\/medicina57020186"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: Implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","article-title":"Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study","volume":"141","author":"Raggi","year":"2020","journal-title":"Circulation"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/7\/1576\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:02:11Z","timestamp":1760122931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/7\/1576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":119,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["nu15071576"],"URL":"https:\/\/doi.org\/10.3390\/nu15071576","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]}}}